PMID: 9546505Apr 18, 1998Paper

Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group

Lancet
T WalshG Bernstein

Abstract

The value of antibiotic prophylaxis before insertion of an intrauterine device (IUD) remains uncertain. We undertook a triple-masked, randomised, placebo-controlled trial to find out whether such prophylaxis reduces the rate of IUD removal within 90 days. 11 clinic sites in southern California enrolled women who requested IUD insertion and were at low risk of sexually transmitted infection according to self-reported medical history. We randomly assigned 1985 participants either 500 mg azithromycin or placebo capsules of identical appearance taken about 1 h before insertion of a Copper T 380A IUD. 118 women did not have an IUD inserted. We followed up 1833 of the remaining 1867 (98%) participants for at least 90 days after insertion. The rate of IUD removal for any reason other than partial expulsion was 3.8% (35/918) in the antibiotic group and 3.4% (31/915) in the placebo group (relative risk 1.1 [95% CI 0.7-1.8]). The two treatment groups sought medical attention with equal frequency (mean 38 visits per 100 women). During the 90 days after IUD insertion, only one woman from each assignment group had salpingitis, as defined by established criteria. Prophylaxis with azithromycin did not affect the likelihood that a woman would ...Continue Reading

Associated Clinical Trials

References

Mar 1, 1991·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·O A LadipoC B Champion
May 1, 1990·British Journal of Obstetrics and Gynaecology·S K SineiV B Bhullar
Feb 1, 1995·JAMA : the Journal of the American Medical Association·K F SchulzD G Altman

❮ Previous
Next ❯

Citations

Nov 1, 2000·Fertility and Sterility·J BouyerN Job-Spira
Mar 17, 2006·The New England Journal of Medicine·Eleanor B Schwarz, Patricia A Lohr
Jun 1, 2004·Sexually Transmitted Infections·H S Mitchell, E Stephens
Mar 2, 2002·Sexually Transmitted Infections·J D C Ross
Jun 22, 2005·Treatments in Endocrinology·Lee P Shulman
Jun 15, 2011·Drugs·Amy StoddardJeffrey F Peipert
Jun 18, 2014·Human Reproduction Update·UNKNOWN ESHRI Capri Workshop Group
Sep 2, 2008·Obstetrics and Gynecology·Paul D Blumenthal, Alison Edelman
May 3, 2013·Obstetrics and Gynecology·David HubacherKristina Gemzell-Danielsson
May 3, 2013·Obstetrics and Gynecology·David E Soper
Sep 1, 2001·The New England Journal of Medicine·D HubacherR Guzmán-Rodríguez
Nov 20, 2012·Journal de gynécologie, obstétrique et biologie de la reproduction·E DerniauxO Graesslin
Mar 13, 2009·La Presse médicale·Jalal Eddine El AmmariMoulay Hassan Farih
Aug 30, 2008·The Medical Clinics of North America·Eve EspeyDana Fotieo
Dec 18, 2007·Contraception·David A Grimes, Daniel R Mishell
May 29, 2007·Contraception·David A GrimesKenneth F Schulz
Dec 3, 2003·Annals of the New York Academy of Sciences·John Guillebaud
Aug 1, 2012·Journal of the American Academy of Nurse Practitioners·Ellen Smith, Alison Moriarty Daley
Apr 13, 2011·The Journal of Obstetrics and Gynaecology Research·Vanja KaliternaZvonimir Barišić
Nov 25, 2000·Obstetrics and Gynecology Clinics of North America·R T Burkman, F A Sonnenberg
Jun 27, 1998·Lancet·D A Hicks
Jan 15, 2004·Obstetrics and Gynecology Clinics of North America·Gretchen S Stuart, Paula M Castaño
Jun 17, 2009·American Journal of Obstetrics and Gynecology·Rebecca H AllenDavid A Grimes
Mar 1, 2015·Current Obstetrics and Gynecology Reports·Bliss Kaneshiro, Jennifer Salcedo
Apr 5, 2017·Expert Opinion on Pharmacotherapy·Rebecca L Taub, Jeffrey T Jensen
Jun 1, 2018·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Rupali DewanAbhinav Dewan
May 2, 2001·The Cochrane Database of Systematic Reviews·D A Grimes, K F Schulz
Jan 19, 2019·The Cochrane Database of Systematic Reviews·Malene Plejdrup HansenChris B Del Mar
Jul 28, 2012·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Kirsten BlackUNKNOWN Intrauterine contraception for Nulliparous women: Translating Research into Action (INTRA) group
May 5, 2000·The Cochrane Database of Systematic Reviews·D A Grimes, K F Schulz
Dec 9, 2016·Archives of Gynecology and Obstetrics·Magdalini Patseadou, Lina Michala
Aug 8, 2014·The Cochrane Database of Systematic Reviews·Babasola O OkusanyaEmmanuel E Effa
Jun 19, 2001·The Cochrane Database of Systematic Reviews·D A Grimes, K F Schulz
Mar 18, 2019·Gynécologie, Obstétrique, Fertilité & Sénologie·X Ah-KitJ-L Brun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.